Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I removed thisday's message: member since 18 March 2009...

Re: I removed thisday's message: member since 18 March 2009...

posted on Mar 18, 2009 08:13AM

It is an interesting question. Does the company have a right under German law to appeal based on the fact that the USPTO rejected the original patent? I don't know but as far as I am concerned we have to base our investment choices on what new business the company can do to generate revenue since the this ruling probably means the well has dried up.

Share
New Message
Please login to post a reply